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Abstract This study was conducted to evaluate the effects of
selenium supplementation on gene expression related to insu-
lin and lipid in infertile women with polycystic ovary syn-
drome (PCOS) candidate for in vitro fertilization (IVF). This
randomized double-blind, placebo-controlled trial was con-
ducted among 40 infertile women with PCOS candidate for
IVF. Subjects were randomly allocated into two groups to
intake either 200-μg selenium (n = 20) or placebo (n = 20)
per day for 8 weeks. Gene expression levels related to insulin
and lipid were quantified in lymphocytes of women with
PCOS candidate for IVF with RT-PCR method. Results of
RT-PCR demonstrated that after the 8-week intervention,
compared with the placebo, selenium supplementation upreg-
ulated gene expression of peroxisome proliferator-activated
receptor gamma (PPAR-γ) (1.06 ± 0.15-fold increase vs.
0.94 ± 0.18-fold reduction, P = 0.02) and glucose transporter
1 (GLUT-1) (1.07 ± 0.20-fold increase vs. 0.87 ± 0.18-fold
reduction, P = 0.003) in lymphocytes of women with PCOS
candidate for IVF. In addition, compared with the placebo,
selenium supplementation downregulated gene expression of
low-density lipoprotein receptor (LDLR) (0.88 ± 0.17-fold
reduction vs. 1.05 ± 0.22-fold increase, P = 0.01) in lympho-
cytes of women with PCOS candidate for IVF. We did not
observe any significant effect of selenium supplementation
on gene expression levels of lipoprotein(a) [LP(a)] in lympho-
cytes of women with PCOS candidate for IVF. Overall, sele-
nium supplementation for 8 weeks in lymphocytes of women
with infertile PCOS candidate for IVF significantly increased
gene expression levels of PPAR-γ and GLUT-1 and signifi-
cantly decreased gene expression levels of LDLR, but did not
affect LP(a).
Clinical trial registration number: http://www.irct.ir:
IRCT201704245623N113.
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Introduction
Polycystic ovary syndrome (PCOS) is a prevalent heteroge-
neous endocrine disorder affecting 6–10% of the women in
reproductive age depending on the diagnostic criteria used [1].
In the in v i t ro f e r t i l i z a t i on ( IVF) se t t i ng , t he
multifolliculogenesis as a response to exogenous gonadotro-
pin stimulation is more frequent in insulin-resistant subjects
who are, therefore, more prone to progress ovarian hyperstim-
ulation syndrome [2, 3]. The peroxisome proliferator-
activated receptor (PPAR-γ) is involved in several metabolic
pathways, such as insulin and lipid metabolism and cellular
differentiation [4]. In addition, PPAR-γ may regulate the ste-
roidogenesis, which in turn contributes to the regulation of
ovarian function [5]. Oxidized low-density lipoprotein (ox-
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LDL) concentrations were also statistically significantly
higher in untreated PCOS women than controls [6], which
are considered as an independent risk factor in cardiovascular
diseases (CVD) [7].
Previous studies have documented that trace elements are
required for normal body function and a deficiency or over-
abundance may result in a diverse range of diseases, including
diabetes and obesity [8–11]. Selenium is an essential micro-
nutrient, which plays an important role in redox reactions,
such as glutathione peroxidase (GPx) and thioredoxin reduc-
tase [12]. More recently, evidence has also been presented that
selenium could affect carbohydrate and fat metabolism.
Selenium, apart from its anti-inflammatory, anticarcinogenic,
and antioxidative effects, influences the way of PPAR-γ ac-
tion [13]. In a study by Gao et al. [14], it was observed that
selenium deficiency inhibited PPAR-γ activity and promoted
nuclear factor-κB (NF-κB) pathway activation. In addition,
selenium supplementation has been demonstrated to increase
the synthesis of a PPAR-γ activator in macrophages [15].
Indeed, increased gene expression of PPAR-γ or transcrip-
tional activity has anti-inflammatory effects [15]. Another
study conducted by Hussein et al. [16] has seen that selenium
supplementation for 3 months among kidney transplant recip-
ients decreased the enhanced susceptibility to lipid peroxida-
tion and ox-LDL.
Since insulin resistance and dyslipidemia in PCOS women
contribute to both reproductive and metabolic disorders [17],
it is important to identify methods to decrease complications
related to insulin resistance and dyslipidemia through lifestyle
changes and pharmacological interventions. This evidence
might support the importance of selenium supplementation
in women with PCOS candidate for IVF. According to the
best of our knowledge, data on the effects of selenium supple-
mentation on gene expression related to insulin and lipid in
women with PCOS candidate for IVF are limited. The aim of
current study was to evaluate the effects of selenium supple-
mentation on gene expression related to insulin and lipid in
women with PCOS candidate for IVF.
Methods
Trial Design and Participants
This randomized double-blind, placebo-controlled trial, regis-
tered in the Iranian website for registration of clinical trials
(http://www.irct.ir: IRCT201704245623N113), was
conducted among 40 infertile women aged 18–40 years old
with PCOS diagnosis according to the Rotterdam criteria [18],
who were IVF candidate from the Research and Clinical
Center for Infertility and the Mahdieh Clinic, Tehran, Iran,
between April 2017 and July 2017. Diagnosis of PCOS was
done according to the Rotterdam criteria [18]. Those with two
of the following criteria were considered as having PCOS: (1)
oligo- and/or anovulation (defined as delayed menses
> 35 days or < 8 spontaneous hemorrhagic episodes/year),
(2) clinical (hirsutism using the modified Ferriman-Gallwey
score of ≥ 8) [18] and/or biochemical s igns of
hyperandrogenism, and (3) polycystic ovaries (12 or more
follicles in each ovary measuring 2–9 mm in diameter and/
or increased ovarian volume > 10 ml3) [18]. Clinical
hyperandrogenism was assessed as the self-reported degree
of hirsutism using the modified Ferriman-Gallwey scoring
method based on a chart displaying degree of hair growth in
nine regions [19] or acne. We excluded pregnant women and
participants with elevated levels of prolactin, thyroid disorder,
and endocrine diseases. This study was conducted in accor-
dance with the Declaration of Helsinki and informed consent
was obtained from all participants. The research was approved
by the ethics committee of the Shahid Beheshti University of
Medical Sciences.
Study Design
Firstly, all participants were matched for age (< 30 and
≥ 30 years) and BMI (< 25 and ≥ 25 kg/m2). Participants were
then randomly divided into two groups to receive either
200-μg selenium as selenium yeast-free other supplements
such as zinc and copper (n = 20) or placebo (n = 20) per day
for 8 weeks. Selenium supplement and placebo (cellulose)
tablets were identical in color, shape, size, and packaging
and were manufactured by Nature Made (California, USA)
and Barij Essence (Kashan, Iran), respectively. To assess the
compliance, participants were asked to bring the medication
container. In addition, participants received a daily reminder
message on their cell phones to take their supplements regu-
larly. Randomization assignment was conducted using
computer-generated random numbers as blindness by a
trained midwife at the clinic. Participants were requested not
to alter their routine physical activity and not to take any
nutritional supplements during the trial or the previous
3 months (wash-out). All patients completed 3-day food re-
cords and three physical activity records at the baseline, 3rd
and 6th weeks, and at the end of trial. Daily macro- and micro-
nutrient intakes were analyzed by nutritionist IV software
(First Databank, San Bruno, CA).
Assessment of Anthropometric Measures
Weight and height of participants were determined in an over-
night fasting status using a standard scale (Seca, Hamburg,
Germany) at the baseline and the end of the intervention.
BMI was calculated as weight in kilograms divided by height
in meters squared.
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Assessment of Outcomes
Gene expression of PPAR-γ and glucose transporter 1
(GLUT-1) were considered as the primary outcomes, and gene
expression levels of low-density lipoprotein receptor (LDLR)
and lipoprotein(a) [LP(a)] were considered as the secondary
outcomes.
Isolation of Lymphocyte, RNA Extraction, and cDNA
Synthesis
Twenty milliliters of blood samples was collected in the anti-
coagulant EDTA tubes. Lymphocytes were isolated using
50% percoll solution (Sigma-Aldrich, Dorset, UK) gradient
by centrifugation for 20 min and 3000 rpm at 4 °C [20].
Total RNA was extracted based on acid guanidinium-
phenol-chloroform procedure using RNX™-plus reagent
(Cinnacolon, Tehran, Iran) according to the manufacturer’s
instructions. RNAs was treated with DNAase I (Fermentas,
Lithuania) for the elimination of any genomic DNA contam-
ination. Concentration, integration, and purity of RNA sam-
ples were determined by spectrometry and gel electrophoresis.
Three micrograms of total RNAwas used for complementary
DNA (cDNA) synthesis with random hexamer and oligo (dT)
18 primers through RevertAid™ reverse transcriptase
(Fermantase, Canada) in the total 20-μl reaction mixture [20].
Real-Time PCR Analysis
Appropriate primers for PPAR-γ, GLUT-1, LDLR, and LP(a)
and glyceraldehyde-3 phosphate dehydrogenase—as an inter-
nal control—were designed (Table 1). Quantitative real-time
PCR was performed by the LightCycler® 96-sequence detec-
tion systems (Roche Diagnostics, Rotkreuz, Switzerland)
using 4 μl of 5× EVA GREEN I master mix (Salise
Biodyne, Japan), 10-ng cDNA, and 200 nM of each forward
and reverse primers in the final volume of 20μl. The PCRwas
performed through the following instruction: an initial dena-
turation at 95 °C for 10 min, followed by 40 cycles of dena-
turation at 95 °C for 10 s, annealing at 54–62.1 °C for 15 s,
and extension at 72 °C for 30 s. The specificity of PCR prod-
ucts was evaluated by 1.5% agarose gel electrophoresis and
melting curve analysis. All experiments were performed at
least in triplicate.
Statistical Methods
To evaluate whether the study variables had been normally
distributed, we used the Kolmogrov-Smirnov test. To detect
differences in anthropometric measures as well as in macro-
and micro-nutrient intakes between the two groups, we ap-
plied independent samples T test. To determine the effects of
selenium supplementation on gene expression related to
insulin and lipid, we used independent samples T test.
Adjustment for changes in baseline values of gene expression
levels related to insulin and lipid, age, and baseline BMI was
conducted by analysis of covariance. The P value of < 0.05
was considered statistically significant. All statistical analyses
used the Statistical Package for Social Science version 18
(SPSS Inc., Chicago, IL, USA).
Results
At the baseline, we invited 45 PCOS women of IVF candi-
date; however, 5 women were excluded from the study be-
cause of not meeting inclusion criteria. Therefore, 40 women
with PCOS candidate for IVF [placebo (n = 20) and selenium
(n = 20)] completed the trial (Fig. 1). On average, the rate of
compliance in our study was high, such that higher than 90%
of supplements were taken throughout the study in both
groups. No side effects were reported following the intake of
selenium in women with PCOS candidate for IVF throughout
the study.
Mean age, height and weight, and BMI at baseline and at
the end of trial were not statistically different between the two
groups (Table 2).
Based on the 3-day dietary records obtained at baseline, at
the end of trial, and throughout the study, we found no signif-
icant difference in mean dietary macro- and micro-nutrient
intakes between the two groups (data not shown).
Results of RT-PCR demonstrated that after the 8-week in-
tervention, compared with the placebo, selenium supplemen-
tation upregulated gene expressions of PPAR-γ (1.06 ± 0.15-
fold increase vs. 0.94 ± 0.18-fold reduction, P = 0.02) and
GLUT-1 (1.07 ± 0.20-fold increase vs. 0.87 ± 0.18-fold reduc-
tion, P = 0.003) in lymphocytes of subjects with PCOS can-
didate for IVF (Figs. 2 and 3). Adjustments for baseline values
of PPAR-γ and GLUT-1, age, and baseline BMI did not in-
fluence our findings (data not shown).
Compared with the placebo, selenium supplementation
downregulated gene expression of LDLR (0.88 ± 0.17-fold
reduction vs. 1.05 ± 0.22-fold increase, P = 0.01) in lympho-
cytes of subjects with PCOS candidate for IVF (Fig. 4).
Adjustments for baseline values of LDL, age, and baseline
BMI did not influence our findings (data not shown).
We did not observe any significant effect of selenium sup-
plementation on gene expression of LP(a) in lymphocytes of
subjects with PCOS candidate for IVF (Fig. 5).
Discussion
We found that selenium supplementation for 8 weeks in lym-
phocytes of PCOS women of candidate for IVF significantly
increased gene expressions of PPAR-γ and GLUT-1,
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significantly decreased gene expression of LDLR, but did not
influence LP(a). To our knowledge, this study is the first re-
port of the effects of selenium supplementation on gene ex-
pression related to insulin and lipid among womenwith PCOS
candidate for IVF. It must be kept in mind that in the current
study, no side effects were reported following supplementa-
tion with selenium in PCOS women candidate for IVF
throughout the study. Mean dietary plus supplemental seleni-
um intake of study participants was lower than upper limits
(400 μg). However, data on the effects of selenium supple-
mentation on health status even in subjects with high dietary
selenium intake are conflicting. For instance, Burk [21] ob-
served that intake of moderate (200 μg/day) to large (600 μg/
day) selenium supplements as selenomethionine was safe
among volunteers ages ≥ 18 years for 16 weeks. However,
Aldosary et al. [22] reported hair loss and dermatitis as the
adverse effects of selenium supplementation.
Subjects with PCOS are susceptible to several metabolic
disorders, such as insulin resistance and dyslipidemia [23, 24].
The current study demonstrated that selenium supplementa-
tion for 8 weeks in lymphocytes of PCOS women candidate
for IVF upregulated gene expression of PPAR-γ and GLUT-1
expressions. Decreased PPAR-γ expression was reported in
PCOS rats compared with the control group [25]. Similarly,
decreased concentrations of PPAR-γ in obese children were
reported compared with normal controls [26]. In a study by
Mueller et al. [27], it was observed that supranutritional sele-
nate in type 2 diabetic animals significantly increased gene
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Fig. 1 Summary of patient flow
diagram
Table 1 Specific primers used for real-time quantitative PCR
Gene Primer Product size (bp) Annealing temperature (°C)
GAPDH F: AAGCTCATTTCCTGGTATGACAACG 126 61.3
R: TCTTCCTCTTGTGCTCTTGCTGG
PPAR-γ F: ATGACAGACCTCAGACAGATTG 210 54
R: AATGTTGGCAGTGGCTCAG
GLUT-1 F: TATCTGAGCATCGTGGCCAT 238 62.1
R: AAGACGTAGGGACCACACAG
LDLR F: ACTTACGGACAGACAGACAG 223 57
R: GGCCACACATCCCATGATTC
Lp(a) F: GACACAGCACGTTCATTCCA 200 55
R: ACACCCCCCTACAATGCTTC
GAPDH glyceraldehyde-3-phosphate dehydrogenase, GLUT-1 glucose transporter 1, Lp(a) lipoprotein(a), LDLR low-density lipoprotein receptor,
PPAR-γ peroxisome proliferator-activated receptor gamma
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expression of PPAR-γ and significantly reduced the activity
of liver cytosolic protein tyrosine phosphatases, which in turn
can be assumed as being responsible for the changes in inter-
mediary metabolism, such as gluconeogenesis and lipid me-
tabolism. In another study, selenium supplementation signifi-
cantly increased the production of 15-deoxy-delta-12,14-
prostaglanin J2 which is an activator of PPAR-γ [15].
Moreover, combined insulin and selenium could significantly
revive normoglycemia and restored the disturbances in insulin
receptor substrate 1, phosphatidylinositide 3-kinases, and
GLUT-4 levels in cardiac muscle of diabetic rats [28].
However, sodium selenite supplementation in mice fed with
a high-fat diet downregulated the mRNA expression of
PPAR-γ and sterol regulatory element-binding protein-1
[29]. PPAR-γ is a member of the nuclear receptor superfamily
and regulates carbohydrate and lipid metabolisms, the im-
mune system, and inflammatory responses [30] .
Downregulation PPAR-γ plays a key role in the pathology
of numerous diseases including diabetes, CVD, and cancer
[31]. Insulin resistance is frequently found in PCOS women,
and this trait has cause-consequence relationships with in-
creased risk of CVD [32], gestational diabetes mellitus, and
type 2 diabetes mellitus [33] as well as dyslipidemia [34]. A
previous meta-analysis has documented that selenium levels
were inversely associated with coronary heart disease risk in
observational studies [35]. Other randomized trials which
have examined the effect of selenium supplements in combi-
nation with other vitamins or minerals on CVD end points
have yielded inconclusive findings [36, 37]. Selenium, aside
from its anti-inflammatory, anticarcinogenic and antioxidative
effects, affects also the way of PPAR-γ action. It has been
reported that insulin resistance can be attenuated by the inhi-
bition of NF-κβ and mitogen-activated protein kinase
(MAPK) signaling pathways and the activation of PPAR-γ
[38]. Selenium intake may increase PPAR-γ expression
through reducing gene expression of pro-inflammatory genes,
inhibiting NF-κβ and p38MAPK activation [39] and the acti-
vation of PPAR-γ [40].
Our study supported that selenium supplementation for
8 weeks in lymphocytes of PCOS women candidate for IVF
upregulated gene expression of LDLR, but did not influence
Lp(a) expression. In a study by Ghaffari et al. [41], it was
observed that selenium plus vitamin E supplementation in dia-
betic rats resulted in significant decreases in ox-LDL and
malondialdehyde levels. In addition, antioxidant supplementa-
tion (selenium, zinc, copper, manganese, N-acetylcysteine, vi-
tamins E and C, and glutamine) for 4 weeks in irradiated hy-
percholesterolemic rabbits significantly decreased the choles-
terol-induced, radiation-enhanced circulating and tissue ox-
LDL concentrations [42]. Few studies have reported the asso-
ciation between selenium and Lp(a) levels. For instance, in a
study by Alissa et al. [43], it was observed that the serum Lp(a),
a coronary risk factor, was strongly related to selenium status in
healthy adults. It has been generally documented that increased
ox-LDL levels contribute to atherogenesis [44]. Ox-LDL can
also promote inflammatory reactions inmonocyte-derivedmac-
rophages, which in turn can result in endothelial dysfunction
[45]. In addition, it has been reported that gene expression
levels of matrix metalloprotease 2 (MMP2) increase in athero-
sclerotic lesions [46]. On the other hand, ox-LDL stimulatory
Table 2 General characteristics of study participants
Placebo group
(n = 20)
Selenium group
(n = 20)
P1
Age (year) 31.4 ± 3.6 31.1 ± 4.7 0.82
Height (cm) 161.0 ± 3.4 162.4 ± 4.5 0.26
Weight at study baseline (kg) 70.7 ± 7.1 69.8 ± 10.7 0.74
Weight at the end of trial (kg) 70.8 ± 7.0 70.0 ± 10.4 0.77
Weight change (kg) 0.1 ± 0.9 0.2 ± 0.8 0.71
BMI at study baseline (kg/m2) 27.3 ± 2.6 26.5 ± 4.1 0.46
BMI at the end of trial (kg/m2) 27.3 ± 2.6 26.6 ± 4.0 0.48
BMI change (kg/m2) 0.04 ± 0.3 0.1 ± 0.3 0.69
Data are means ± SDs
1Obtained from independent T test
PPAR-
P=0.02
0.0
0.5
1.0
1.5
 Placebo                    Selenium
esaercni
dloF
γ
Fig. 2 Effect of 8-week supplementation with selenium or placebo on
expression ratio of PPAR-γ gene in lymphocytes of PCOSwomen of IVF
candidate
GLUT-1
0.0
0.5
1.0
1.5
P=0.003
Placebo                    Selenium
esaercni
dloF
Fig. 3 Effect of 8-week supplementation with selenium or placebo on
expression ratio of GLUT-1 gene in lymphocytes of PCOSwomen of IVF
candidate
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effect on gene expression of MMP2 in smooth muscle cells has
also been documented experimentally [47]. ox-LDL as product
of lipid peroxidation is generated under high levels of
unscavenged free radicals and can result in the diabetes-
associated pancreatic damage [48]. Selenium is an essential
component of the erythrocyte glutathione system [49], which
functions as part of an antioxidant defense to protect polyun-
saturated fatty acids and proteins from the damaging effects of
free radicals, peroxides, and lipid hydroperoxides [50].
Decreased ox-LDL levels following the supplementation of
selenium in the current study may have indirectly resulted from
decreased ROS, free radicals, and lipid peroxidation.
The current study had few limitations. Due to funding lim-
itations, we did not evaluate selenium or GPx levels at baseline
and at the end of trial. In addition, we could not assess gene
expression levels related to inflammation and oxidative stress.
Overall, selenium supplementation for 8 weeks in lympho-
cytes of infertile PCOSwomen candidate for IVF significantly
increased gene expressions of PPAR-γ and GLUT-1 and sig-
nificantly decreased gene expression of LDLR, but did not
affect LP(a).
Authors’ Contributions ZA contributed in conception, design, statis-
tical analysis, and drafting of the manuscript. SZ, ZH, FF, ZR, and EA
contributed in data collection and manuscript drafting. All authors ap-
proved the final version for submission. ZA supervised the
study.Funding InformationThis study was founded by a grant from the
vice-chancellor for research, Shahid Beheshti, University of Medical
Sciences, Tehran, Iran.Compliance with Ethical Standards This
study was conducted in accordance with the Declaration of Helsinki,
and informed consent was obtained from all participants. The research
was approved by the ethics committee of Shahid Beheshti University of
Medical Sciences.
Conflict of Interest The authors declare that they have no conflict of
interest.
References
1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz
BO (2004) The prevalence and features of the polycystic ovary
syndrome in an unselected population. J Clin Endocrinol Metab
89:2745–2749
2. Fulghesu AM, Villa P, Pavone Vet al (1997) The impact of insulin
secretion on the ovarian response to exogenous gonadotropins in
polycystic ovary syndrome. J Clin Endocrinol Metab 82:644–648
3. Dale PO, Tanbo T, Haug E, Abyholm T (1998) The impact of
insulin resistance on the outcome of ovulation induction with
low-dose follicle stimulating hormone in women with polycystic
ovary syndrome. Hum Reprod 13:567–570
4. Uno K, Katagiri H, Yamada T et al (2006) Neuronal pathway from
the liver modulates energy expenditure and systemic insulin sensi-
tivity. Science 312:1656–1659
5. Puttabyatappa M, Vandevoort CA, Chaffin CL (2010) hCG-
induced down-regulation of PPARgamma and liver X receptors
promotes periovulatory progesterone synthesis by macaque granu-
losa cells. Endocrinology 151:5865–5872
6. Carlioglu A, Kaygusuz I, Karakurt F et al (2014) The platelet acti-
vating factor acetyl hydrolase, oxidized low-density lipoprotein,
paraoxonase 1 and arylesterase levels in treated and untreated pa-
tients with polycystic ovary syndrome. Arch Gynecol Obstet 290:
929–935
7. Liu ML, Ylitalo K, Salonen R, Salonen JT, Taskinen MR (2004)
Circulating oxidized low-density lipoprotein and its association
with carotid intima-media thickness in asymptomatic members of
familial combined hyperlipidemia families. Arterioscler Thromb
Vasc Biol 24:1492–1497
8. Navarro-AlarconM, Cabrera-Vique C (2008) Selenium in food and
the human body: a review. Sci Total Environ 400:115–141
9. Jamilian M, Samimi M, Afshar Ebrahimi F et al (2017) Effects of
selenium supplementation on gene expression levels of inflamma-
tory cytokines and vascular endothelial growth factor in patients
with gestational diabetes. Biol Trace Elem Res. https://doi.org/10.
1007/s12011-017-1045-8
10. El Dib R, Gameiro OL, Ogata MS et al (2015) Zinc supplementa-
tion for the prevention of type 2 diabetes mellitus in adults with
insulin resistance. Cochrane database Syst rev:CD005525
11. Asemi Z, Jamilian M, Mesdaghinia E, Esmaillzadeh A (2015)
Effects of selenium supplementation on glucose homeostasis, in-
flammation, and oxidative stress in gestational diabetes: random-
ized, double-blind, placebo-controlled trial. Nutrition 31:1235–
1242
12. Lu J, Holmgren A (2009) Selenoproteins. J Biol Chem 284:723–
727
Lp(a)
0.0
0.5
1.0
1.5
P=0.80
Placebo                    Selenium
esaercni
dloF
Fig. 5 Effect of 8-week supplementation with selenium or placebo on
expression ratio of Lp(a) gene in lymphocytes of PCOS women of IVF
candidate. GLUT-1, glucose transporter 1; Lp(a), lipoprotein(a); LDLR,
low-density lipoprotein receptor; PCOS, polycystic ovary syndrome;
PPAR-γ, peroxisome proliferator-activated receptor gamma
LDLR
0.0
0.5
1.0
1.5
P=0.01
Placebo                    Selenium
esaercni
dloF
Fig. 4 Effect of 8-week supplementation with selenium or placebo on
expression ratio of LDLR gene in lymphocytes of PCOS women of IVF
candidate
The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile... 223
13. Donma MM, Donma O (2016) Promising link between selenium
and peroxisome proliferator activated receptor gamma in the treat-
ment protocols of obesity as well as depression. Med Hypotheses
89:79–83
14. Gao X, Zhang Z, Li Y et al (2016) Selenium deficiency deteriorate
the inflammation of S. aureus infection via regulating NF-kappaB
and PPAR-gamma in mammary gland of mice. Biol Trace Elem
Res 172:140–147
15. Vunta H, Davis F, Palempalli UD et al (2007) The anti-
inflammatory effects of selenium are mediated through 15-deoxy-
Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282:
17964–17973
16. Hussein O, Rosenblat M, Refael G, Aviram M (1997) Dietary se-
lenium increases cellular glutathione peroxidase activity and re-
duces the enhanced susceptibility to lipid peroxidation of plasma
and low-density lipoprotein in kidney transplant recipients.
Transplantation 63:679–685
17. Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the
polycystic ovary syndrome revisited: an update on mechanisms and
implications. Endocr Rev 33:981–1030
18. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus
Workshop Group (2004) Revised 2003 consensus on diagnostic
criteria and long-term health risks related to polycystic ovary syn-
drome. Fertil Steril 81:19–25
19. Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism:
implications, etiology, andmanagement. Am JObstet Gynecol 140:
815–830
20. Gmelig-Meyling F, Waldmann TA (1980) Separation of human
blood monocytes and lymphocytes on a continuous Percoll gradi-
ent. J Immunol Methods 33:1–9
21. Burk RF, Norsworthy BK, Hill KE, Motley AK, Byrne DW (2006)
Effects of chemical form of selenium on plasma biomarkers in a
high-dose human supplementation trial. Cancer Epidemiol
Biomark Prev 15:804–810
22. Aldosary BM, Sutter ME, Schwartz M, Morgan BW (2012) Case
series of selenium toxicity from a nutritional supplement. Clin
Toxicol (Phila) 50:57–64
23. Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M,
Esmaillzadeh A (2015) Calcium plus vitamin D supplementation
affects glucose metabolism and lipid concentrations in overweight
and obese vitamin D deficient women with polycystic ovary syn-
drome. Clin Nutr 34:586–592
24. Foroozanfard F, Jamilian M, Bahmani F et al (2015) Calcium plus
vitamin D supplementation influences biomarkers of inflammation
and oxidative stress in overweight and vitamin D-deficient women
with polycystic ovary syndrome: a randomized double-blind place-
bo-controlled clinical trial. Clin Endocrinol 83:888–894
25. Wang YX, ZhuWJ, Xie BG (2014) Expression of PPAR-gamma in
adipose tissue of rats with polycystic ovary syndrome induced by
DHEA. Mol Med Rep 9:889–893
26. Akyurek N, Aycan Z, Cetinkaya S, Akyurek O, Yilmaz Agladioglu
S, Ertan U (2013) Peroxisome proliferator activated receptor
(PPAR)-gamma concentrations in childhood obesity. Scand J Clin
Lab Invest 73:355–360
27. Mueller AS, Pallauf J (2006) Compendium of the antidiabetic ef-
fects of supranutritional selenate doses. In vivo and in vitro inves-
tigations with type II diabetic db/db mice. J Nutr Biochem 17:548–
560
28. TJ X, Liu Y, Yuan B (2011) Effect of insulin in combination with
selenium on Irs/PI3K-mediated GLUT4 expression in cardiac mus-
cle of diabetic rats. Eur Rev Med Pharmacol Sci 15:1452–1460
29. Nido SA, Shituleni SA, Mengistu BM et al (2016) Effects of
selenium-enriched probiotics on lipid metabolism, antioxidative
status, histopathological lesions, and related gene expression in
mice fed a high-fat diet. Biol Trace Elem Res 171:399–409
30. Zhou F, Shi LB, Zhang SY (2017) Ovarian fibrosis: a phenomenon
of concern. Chin Med J 130:365–371
31. Strakova N, Ehrmann J, Bartos J, Malikova J, Dolezel J, Kolar Z
(2005) Peroxisome proliferator-activated receptors (PPAR) agonists
affect cell viability, apoptosis and expression of cell cycle related
proteins in cell lines of glial brain tumors. Neoplasma 52:126–136
32. Legro RS (2003) Polycystic ovary syndrome and cardiovascular
disease: a premature association? Endocr Rev 24:302–312
33. Cassar S, Teede HJ, Harrison CL, Joham AE,Moran LJ, Stepto NK
(2015) Biomarkers and insulin sensitivity in women with PCOS:
characteristics and predictive capacity. Clin Endocrinol 83:50–58
34. Unfer V, Porcaro G (2014) Updates on the myo-inositol plus D-
chiro-inositol combined therapy in polycystic ovary syndrome.
Expert Rev Clin Pharmacol 7:623–631
35. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, Guallar E
(2006) Selenium and coronary heart disease: a meta-analysis. Am
J Clin Nutr 84:762–773
36. Brown BG, Zhao XQ, Chait A et al (2001) Simvastatin and niacin,
antioxidant vitamins, or the combination for the prevention of cor-
onary disease. N Engl J Med 345:1583–1592
37. Hercberg S (2006) The SU.VI.MAX study, a randomized, placebo-
controlled trial on the effects of antioxidant vitamins and minerals
on health. Ann Pharm Fr 64:397–401
38. Li R, Xu X, Chen C et al (2015) CYP2J2 Attenuates metabolic
dysfunction in diabetic mice by reducing hepatic inflammation via
the PPAR gamma. Am J Physiol Endocrinol Metab 308:E270–
E282
39. Zhang W, Zhang R, Wang T et al (2014) Selenium inhibits LPS-
induced pro-inflammatory gene expression by modulating MAPK
and NF-kappaB signaling pathways in mouse mammary epithelial
cells in primary culture. Inflammation 37:478–485
40. Gandhi UH, Kaushal N, Ravindra KC et al (2011) Selenoprotein-
dependent up-regulation of hematopoietic prostaglandin D2 syn-
thase in macrophages is mediated through the activation of perox-
isome proliferator-activated receptor (PPAR) gamma. J Biol Chem
286:27471–27482
41. Ghaffari T, Nouri M, Irannejad E, Rashidi MR (2011) Effect of
vitamin e and selenium supplement on paraoxonase-1 activity, ox-
idized low density lipoprotein and antioxidant defense in diabetic
rats. Bioimpacts 1:121–128
42. Leborgne L, Pakala R, Dilcher C et al (2005) Effect of antioxidants
on atherosclerotic plaque formation in balloon-denuded and irradi-
ated hypercholesterolemic rabbits. J Cardiovasc Pharmacol 46:
540–547
43. Alissa EM, Ahmed WH, Al-ama N, Ferns GA (2008) Selenium
status and cardiovascular risk profile in healthy adult Saudi males.
Molecules 14:141–159
44. Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T,
Morooka S (2001) Clinical significance of antibody against oxi-
dized low density lipoprotein in patients with atherosclerotic coro-
nary artery disease. J Am Coll Cardiol 37:775–779
45. Galle J, Hansen-Hagge T, Wanner C, Seibold S (2006) Impact of
oxidized low density lipoprotein on vascular cells. Atherosclerosis
185:219–226
46. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A
(2006) Effect of MMP-2 deficiency on atherosclerotic lesion for-
mation in apoE-deficient mice. Arterioscler Thromb Vasc Biol 26:
1120–1125
47. Auge N, Maupas-Schwalm F, Elbaz M et al (2004) Role for matrix
metalloproteinase-2 in oxidized low-density lipoprotein-induced
activation of the sphingomyelin/ceramide pathway and smooth
muscle cell proliferation. Circulation 110:571–578
48. Ghaffari T, Nouri M, Saei AA, Rashidi MR (2012) Aldehyde and
xanthine oxidase activities in tissues of streptozotocin-induced dia-
betic rats: effects of vitamin E and selenium supplementation. Biol
Trace Elem Res 147:217–225
224 Modarres et al.
49. Ozturk IC, Batcioglu K, Karatas F, Hazneci E, Genc M (2008)
Comparison of plasma malondialdehyde, glutathione, glutathione
peroxidase, hydroxyproline and selenium levels in patients with
vitiligo and healthy controls. Indian J Dermatol 53:106–110
50. Rohr-Udilova N, Sieghart W, Eferl R et al (2012) Antagonistic
effects of selenium and lipid peroxides on growth control in early
hepatocellular carcinoma. Hepatology 55:1112–1121
The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile... 225
